The National Medicines Institute found in this batch of the medicinal product the presence of particles visible to the naked eye in two of twenty tested vials, causing the batch to fail quality requirements for solution appearance. Potential effects: post-infusion complications, inflammatory reactions, embolism by particles, lack of safety during infusion.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use the medicine from batch ZD033. Patients and healthcare facilities should check the batch number, stop using products from this batch and return them to the pharmacy or wholesaler; if the me...
The Chief Pharmaceutical Inspector withdrew batch ZD033 of Osporil from the market throughout the country and prohibited placing this batch on the market, granting the decision immediate enforceabilit...
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related